Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6042469 | Pediatric Neurology | 2013 | 6 Pages |
Abstract
Mammalian target of rapamycin inhibitors have been shown to be an effective treatment of various aspects of tuberous sclerosis complex, including subependymal giant cell astrocytomas. Both mammalian target of rapamycin inhibitors and surgery have a role in the treatment of subependymal giant cell astrocytomas. Various subependymal giant cell astrocytoma-related conditions favor a certain treatment.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Jonathan MD, E. Steve MD, Ute MD, Sergiusz MD, Mary Kay MD, Howard L. MD, David N. MD, Henry Z. MD,